NIH- and Burroughs Wellcome–funded investigator with pending patents in antibiotic heteroresistance. Research integrates microbiology, immunology, and pharmacoepidemiology to elucidate resistance dynamics and inform diagnostics, stewardship, and treatment strategies across clinically relevant pathogens and probiotic contexts.